Detalhe da pesquisa
1.
Genetic stabilization of attenuated oral vaccines against poliovirus types 1 and 3.
Nature
; 619(7968): 135-142, 2023 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-37316671
2.
Safety of the novel oral poliovirus vaccine type 2 (nOPV2) in infants and young children aged 1 to <5 years and lot-to-lot consistency of the immune response to nOPV2 in infants in The Gambia: a phase 3, double-blind, randomised controlled trial.
Lancet
; 403(10432): 1164-1175, 2024 Mar 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-38402887
3.
Fecal Shedding of 2 Novel Live Attenuated Oral Poliovirus Type 2 Vaccine Candidates by Healthy Infants Administered Bivalent Oral Poliovirus Vaccine/Inactivated Poliovirus Vaccine: 2 Randomized Clinical Trials.
J Infect Dis
; 226(5): 852-861, 2022 09 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-34610135
4.
Safety and immunogenicity of two novel type 2 oral poliovirus vaccine candidates compared with a monovalent type 2 oral poliovirus vaccine in children and infants: two clinical trials.
Lancet
; 397(10268): 27-38, 2021 01 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33308427
5.
Safety and immunogenicity of two novel type 2 oral poliovirus vaccine candidates compared with a monovalent type 2 oral poliovirus vaccine in healthy adults: two clinical trials.
Lancet
; 397(10268): 39-50, 2021 01 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33308429
6.
Genetic Characterization of Novel Oral Polio Vaccine Type 2 Viruses During Initial Use Phase Under Emergency Use Listing - Worldwide, March-October 2021.
MMWR Morb Mortal Wkly Rep
; 71(24): 786-790, 2022 Jun 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-35709073
7.
The safety and immunogenicity of two novel live attenuated monovalent (serotype 2) oral poliovirus vaccines in healthy adults: a double-blind, single-centre phase 1 study.
Lancet
; 394(10193): 148-158, 2019 07 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-31174831
8.
Improvement of the qmosRT-PCR Assay and Its Application for the Detection and Quantitation of the Three Serotypes of the Novel Oral Polio Vaccine in Stool Samples.
Vaccines (Basel)
; 11(11)2023 Nov 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-38006061
9.
Enabling accelerated vaccine roll-out for Public Health Emergencies of International Concern (PHEICs): Novel Oral Polio Vaccine type 2 (nOPV2) experience.
Vaccine
; 41 Suppl 1: A122-A127, 2023 04 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35307230
10.
Quantitative RT-PCR Assays for Quantification of Undesirable Mutants in the Novel Type 2 Oral Poliovirus Vaccine.
Vaccines (Basel)
; 10(9)2022 Aug 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-36146473
11.
Genetic and phenotypic stability of poliovirus shed from infants who received novel type 2 or Sabin type 2 oral poliovirus vaccines in Panama: an analysis of two clinical trials.
Lancet Microbe
; 3(12): e912-e921, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36332645
12.
Evaluating stability of attenuated Sabin and two novel type 2 oral poliovirus vaccines in children.
NPJ Vaccines
; 7(1): 19, 2022 Feb 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-35149714
13.
Development of a Quantitative One-Step RT-PCR Method for the Detection of Sabin 2 Virus Contamination in a Novel Oral Poliovirus Vaccine Type 2.
Vaccines (Basel)
; 9(7)2021 Jun 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-34201447
14.
Evaluation and validation of next-generation sequencing to support lot release for a novel type 2 oral poliovirus vaccine.
Vaccine X
; 8: 100102, 2021 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-34195600
15.
Assessment of genetic changes and neurovirulence of shed Sabin and novel type 2 oral polio vaccine viruses.
NPJ Vaccines
; 6(1): 94, 2021 Jul 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-34326330
16.
Engineering the Live-Attenuated Polio Vaccine to Prevent Reversion to Virulence.
Cell Host Microbe
; 27(5): 736-751.e8, 2020 05 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-32330425
17.
Scaleable purification of adenovirus vectors.
Methods Mol Biol
; 434: 13-23, 2008.
Artigo
em Inglês
| MEDLINE | ID: mdl-18470636
18.
Sterilizing filtration of plasmid DNA: effects of plasmid concentration, molecular weight, and conformation.
Biotechnol Prog
; 22(2): 465-70, 2006.
Artigo
em Inglês
| MEDLINE | ID: mdl-16599564
19.
Serotype specificity of adenovirus purification using anion-exchange chromatography.
Hum Gene Ther
; 16(11): 1346-53, 2005 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-16259569
20.
Development of a purification process for adenovirus: controlling virus aggregation to improve the clearance of host cell DNA.
Biotechnol Prog
; 21(2): 466-72, 2005.
Artigo
em Inglês
| MEDLINE | ID: mdl-15801787